K. Jurianz

About

Dr. K. Jurianz is a leading figure in the field of pulmonary stereotactic body radiotherapy (SBRT), with a focused research agenda dedicated to standardizing treatment planning for early-stage non-small cell lung cancer (NSCLC). Their seminal work, the 2017 "Planning benchmark study for SBRT of early stage NSCLC," which has garnered 54 citations, systematically revealed substantial interinstitutional and intertechnology variations in dose prescription and target volume coverage. Building on this critical finding, Dr. Jurianz’s more recent research (2021) proposes a novel solution: prescribing dose to the mean internal target volume dose. This contribution directly addresses the root cause of inconsistency by normalizing the dose profile inside the target, regardless of the specific SBRT technology used. By advocating for this standardized methodology, Dr. Jurianz is actively improving the reproducibility and comparability of pulmonary SBRT across clinics, a vital step for both clinical practice and multi-institutional trials. Their work is essential reading for any radiation oncology researcher or physicist seeking to harmonize lung SBRT protocols and enhance treatment quality.

Research Focus

Key Achievements

Top Papers

1. 1
   Planning benchmark study for SBRT of early stage NSCLC

   54 citations · 2017
2. 2
   Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose

   11 citations · 2021

Key Collaborators

Contact & Links